Asthma Data Innovation Demonstration Project

NCT02162576 | Completed Results DMC

• 1 other identifier: PH LVL - 40202
• Study Type: interventional
• Target: 95
• Locations: 1 country
• Sites: 1

Brief Summary

Propeller Health is collaborating with the City of Louisville and other local partners to carry out a focused demonstration project that will evaluate the effectiveness of the Propeller Health approach to asthma management while exploring means to use real-time data on asthma exacerbations in a public health setting. The Asthma Data Innovation Demonstration Project (ADID) will use wireless sensor technology to develop spatial and temporal data on the use of rescue inhalers by 120 study subjects with asthma in the Louisville metropolitan area. Propeller Health will process these data to support two general strategies. Asthma self management: Rescue inhaler actuation data will be compiled into individualized feedback reports to support asthma self management. Propeller Health will combine information on individual rescue inhaler actuations with evidence-based asthma management tips into real-time reports that will be provided to subjects. ADID staff will evaluate any resulting improvements in asthma control that may be based on this information. Subjects may share reports with their healthcare providers. Municipal purposes: The second strategy is to provide aggregated and de-identified, spatial and temporal asthma rescue inhaler actuation data to City personnel and authorized public health researchers in Louisville. These data will show the times and locations of the use of rescue inhalers by the 120 study subjects throughout the greater Louisville area. ADID staff will work with City personnel and researchers to investigate how this unprecedented level of detailed information on exacerbations can be used best to increase public awareness of environmental triggers while supporting public health surveillance efforts around respiratory diseases.

Conditions

Asthma; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Keywords

asthma; asthma control; healthcare utilization costs; community hotspots; public health research

Outcome Measures

Primary Outcomes (1)

• Change in Rescue Inhaler Actuations/Person/Day

  The Propeller Health sensor permits the capture of objective time and location data on each actuation of the rescue inhaler. The mean number of rescue inhaler events per participant per day will be assessed for each day in the study, and the difference between the baseline month and all subsequent months will be evaluated.

  Change from baseline to study exit, up to 13 months

Secondary Outcomes (2)

• Percent Change in the Proportion of Participants With an Asthma-free Day

  Change from baseline period to study exit (approximately 13 months)

• Percent Change in the Proportion of Participants With Well-controlled Asthma

  Baseline and study exit (approximately 13 months)

Study Arms (1)

Propeller Health intervention group

OTHER

All participants attached the Propeller sensor to their SABA medications and tracked the time and location of use for up to 13 months, to capture seasonal variation in medication use, symptoms and environmental triggers. The first 30-day run-in period served as a control period to assess levels of asthma control and SABA use; subject actuations were tracked, but participants and physicians did not receive their data or feedback. After the run-in period, participants received the full intervention for 12 months (see intervention for description).

Device: Propeller Health intervention

Interventions

Propeller Health intervention DEVICE

The Propeller intervention works through the provision of information to patients and their providers. With the Propeller sensor device in place, each actuation of a patient's rescue inhaler is recorded with an automatic time stamp and geographic location. Actuation data are then securely transmitted to Propeller Health where the information is also compiled into individual reports via mobile apps, online dashboards, email reports and text message reminders that are returned to the patient. This communication provides an ongoing assessment of their management based on the national guidelines, together with personalized information to help encourage and support self-management. Each participant was invited to share reports with his or her healthcare provider, but this was not required.

Also known as: Asthmapolis

Propeller Health intervention group

Eligibility Criteria

• Age: 5 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Self-reported provider diagnosis of asthma
• Prescription for Short Acting Beta Agonist (SABA) at study intake

You may not qualify if:

• Subject is under the age of 5 at the beginning of the study
• Subject does not speak English
• Subject does not have access to the Internet or email to receive reports
• Subject has substantial co-morbidity (self-reported provider diagnosis of COPD)

Sponsors & Collaborators

• David Van Sickle: lead
• Foundation for a Healthy Kentucky: collaborator
• Norton Healthcare Foundation: collaborator
• Owsley Brown Charitable Foundation: collaborator

Study Sites (1)

Jefferson County

Louisville, Kentucky, 40202, United States

Location

Related Publications (2)

• Barrett M, Combs V, Su JG, Henderson K, Tuffli M; AIR Louisville Collaborative; AIR Louisville Collaborative. AIR Louisville: Addressing Asthma With Technology, Crowdsourcing, Cross-Sector Collaboration, And Policy. Health Aff (Millwood). 2018 Apr;37(4):525-534. doi: 10.1377/hlthaff.2017.1315.

  PMID: 29608361 RESULT

• Barrett MA, Humblet O, Marcus JE, Henderson K, Smith T, Eid N, Sublett JW, Renda A, Nesbitt L, Van Sickle D, Stempel D, Sublett JL. Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy Asthma Immunol. 2017 Nov;119(5):415-421.e1. doi: 10.1016/j.anai.2017.08.002.

  PMID: 29150069 RESULT

MeSH Terms

Conditions

Asthma; Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Results Point of Contact

• Title: Dr. Meredith Barrett
• Organization: Propeller Health

meredith.barrett@propellerhealth.com

415-409-9258

Study Officials

• David Van Sickle, PhD

  Propeller Health

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: CEO

Study Record Dates

• First Submitted: June 6, 2014
• First Posted: June 12, 2014
• Study Start: June 1, 2012
• Primary Completion: January 1, 2014
• Study Completion: January 1, 2014
• Last Updated: July 20, 2021
• Results First Posted: December 26, 2017

Record last verified: 2021-07

Locations

US (1)